Inside the research

Hawkins, Inc.

HWKN Research profile · latest available data

Price overview

$129.03

▲ +2.41 (+1.9%)

52w hi$182.56
52w lo$117.67
Vol186.90K
As of25 Sep 2026

The Verdict

Sell

Our score -0.63

Short-0.63
Medium-0.71
Long-0.46

computed 2026-09-27

Key fundamentals

Hawkins, Inc.

Basic Materials · Specialty Chemicals

Market cap$2.69B
Enterprise value$2.94B
Trailing P/E33.43x
Forward P/E25.81x
EV / EBITDA17.66x
P / S (ttm)2.44x
Profit margin7.3%
Return on equity15.6%
Revenue growth+7.6%
Earnings growth-3.6%
Debt / equity47.01

Layer Breakdown

LayerRawContribution
Fundamental+0.14
Sector-0.02
Technical-0.53
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Hawkins, Inc. operates as a water treatment and specialty ingredients company in the United States. The company operates through three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The Water Treatment segment provides chemicals, filtration media and systems, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agricultural water. This segment also sells and services equipment, including tanks, valves, and pumps. The Food and Health Sciences segment provide ingredient distribution, processing, and formulation solutions, such as base chemistry, acid-based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients to nutrition, food, pharmaceutical, and agricultural markets. The Industrial Solutions segment offers industrial chemicals, products, and services such as acids and alkalis, liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide to industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing industries. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.

United States · www.hawkinsinc.com

Risk Metrics

Beta vs SPX0.90
Corr SPX0.38
Annual vol38.1%
Annual ret+10.3%
Sharpe0.27
Max DD-36.3%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-08-14Officer / Director Changeread
2026-08-03Shareholder Voteread
2026-07-29Earnings Releaseread
2026-05-19Officer / Director Changeread
2026-05-13Earnings Releaseread
2026-01-28Earnings Releaseread
2025-12-19Officer / Director Changeread
2025-10-29Earnings Releaseread
2025-08-08Reg FD Disclosureread
2025-08-01Officer / Director Changeread
2025-07-30Earnings Releaseread
2025-05-14Earnings Releaseread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-07Hawkins Patrick H.Director, Officer, CEO ANGift580—
2026-07-29Schumacher Mary J.DirectorGrant721—
2026-07-29Faulconbridge James ADirectorGrant721—
2026-07-29WRIGHT JEFFREY LDirectorGrant721—
2026-07-29Tang YiDirectorGrant721—
2026-07-29Stauber Daniel JDirectorGrant721—
2026-07-29THOMPSON JAMES TDirectorGrant721—
2026-07-29Spethmann Jeffrey EDirectorGrant721—
2026-05-13Rozeboom Shirley A.Officer, VP HEALTH AND NUGrant1.91K—
2026-05-13Lange Douglas A.Officer, VP - WATER TREATGrant1.99K—

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders8
Top-5 share99.6%
HHI7,405 (concentrated)

Top Holders

HolderValueShares
State Street Corp$150.89M1.06M
Capital Research / Capital World$9.03M63.54K
Fidelity / FMR LLC$9.01M63.44K
Renaissance Technologies$4.79M33.70K
AQR Capital Management$1.60M11.25K
Millennium Management$500.76K3.52K
Citadel Advisors$241.57K1.70K
T. Rowe Price Group$8.43K59.32K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-148-Kview
2026-08-114view
2026-08-038-Kview
2026-07-314view
2026-07-314view
2026-07-314view
2026-07-314view
2026-07-314view
2026-07-314view
2026-07-314view
2026-07-2910-Qview
2026-07-298-Kview
2026-06-18DEF 14Aview
2026-06-18DEFA14Aview
2026-06-18ARSview

The Long Run

FY 2011–2026 · 15 years

LineLatestCAGRTrend
Revenue$1.08B+9.7%
Gross profit$193.64M+8.0%
Operating income$119.17M+9.9%
Net income$75.36M+9.7%
Cash from ops$159.50M+11.7%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$126.24$129.19$125.64$129.03186.90K
Sep 24$123.73$126.98$123.20$126.62108.80K
Sep 23$124.45$126.91$122.99$123.9990.50K
Sep 22$125.69$127.59$124.48$124.55173.60K
Sep 21$122.54$125.98$121.82$125.39151.10K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →